The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.
Next-generation sequencing of the COVID-19 virus is providing powerful metagenomic data, which, combined with clinical data, will inform the search for effective treatments, as reported in the peer-reviewed journal Pediatric Allergy, Immunology, and Pulmonology.
The latest generation of tetracyclines - a class of powerful, first-line antibiotics - was designed to thwart the two most common ways bacteria resist such drugs.
As scientists across the globe race to develop a vaccine against SARS-CoV-2, the coronavirus that causes COVID-19, an international team led by Davide Corti at Vir Biotechnology and David Veesler at the University of Washington has been working around the clock on a complementary approach - identifying neutralizing antibodies that could be used as a preventative treatment or as a post-exposure therapy.
An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the cause of COVID-19.
A molecular biologist is working with a world leader in artificial intelligence-based drug discovery to help find a molecule that could prevent SARS-CoV-2.
Allergen immunotherapy provides long-lasting relief to people suffering from allergies, but the therapy can last years and requires large amounts of allergen.
Scientists at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) revealed a novel mechanism through which the immune system can control autoimmunity and cancer.
COVID-19 is causing organ destruction and death, and physicians are replacing the filter in a kidney dialysis machine to trap these tiny proteins.
For people with allergies, contact with pollen leads to symptoms such as sneezing, rhinitis, and watery eyes.
The hunt for an effective treatment for COVID-19 has led one team of researchers to find an improbable ally for their work: a llama named Winter.
A link has been discovered between a common gene defect and eczema, nasal blockage, and wheeze among babies as young as six months, according to a new study.
Although antibiotics are known to save lives, their use also supports the evolution and spread of antibiotic-resistant strains.
Stanford University chemist Paul Wender and his colleagues are working to improve treatments for cancer, HIV and Alzheimer's - and they are betting that a drab, weedy marine invertebrate is the means to achieving that end.
AZoLifeSciences speaks to Dr.Urs Schaffner about his latest research into relieving allergy sufferers.
A study has been launched to understand how the body's immune system responds to COVID-19, including if and when a person could be re-infected with the virus.
Research findings suggest gut microbes can affect allergic immune responses.
Brands in the cookies category are using banana powder to provide a new sensory experience for consumers, according to GlobalData a leading data and analytics company.
At St. Jude Children’s Research Hospital, researchers have generated a database that detects gene-regulatory mechanisms in immune cells that promote Type 1 diabetes.
Scientists at Aarhus University have described the structure of an IgE antibody for the very first time.